logo
logo

DPBIO and Leveragen Announce Strategic Partnership to Advance Antibody Discovery

DPBIO and Leveragen Announce Strategic Partnership to Advance Antibody Discovery

12/12/24, 1:42 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgboston
Industry
biotechnology
Type
partnership
DPBIO and Leveragen, Inc. have announced a strategic partnership to accelerate innovations in antibody drug development. The collaboration aims to overcome critical challenges in antibody discovery and deliver transformative solutions for complex therapeutic targets by integrating advanced technologies.

Company Info

Company
Dapu Biotechnology (DPBIO) and Leveragen
Location
boston, massachusetts, united states
Additional Info
Dapu Biotechnology (DPBIO) is an industry leader in droplet microfluidic technology. Leveragen, Inc. is a Boston-based biotech developing advanced genetic models for antibody discovery.